Stock THAR THARIMMUNE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Tharimmune, Inc.

Equities

THAR

US4327053090

Market Closed - Nasdaq
Other stock markets
 03:59:37 2024-06-10 pm EDT 		5-day change 1st Jan Change
3.47 USD -33.27% Intraday chart for Tharimmune, Inc. -31.35% -54.55%
Jun. 10 Tharimmune, Inc. Announces Positive Results of Phase 1 Trial in Healthy Subjects with TH104, its Lead Candidate for Moderate-To-Severe Pruritus in Primary Biliary Cholangitis CI
May. 25 Certain Warrants of Tharimmune, Inc. are subject to a Lock-Up Agreement Ending on 25-MAY-2024. CI
753fa6afdba384d827134f8876.GX2cSlzrZwsbI3_0-39NX84UG30oQbhrIyhgsu4ayHI.VUzZfCySPjt8ehq4rSp9NY1TLytvB5UsRkUz9tpCrihhS_QDA5odUXwQRw~866dc911e87eea5d769fc24a40f1564a
  1. Stock Market
  2. Equities
  3. THAR Stock
  4. Charts Tharimmune, Inc.
  5. News Chart